Putnam Investments’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-29,599
| Closed | -$464K | – | 943 |
|
|
2019
Q1 | $464K | Hold |
29,599
| – | – | ﹤0.01% | 799 |
|
|
2018
Q4 | $456K | Buy |
+29,599
| New | +$456K | ﹤0.01% | 830 |
|
|
2017
Q2 | – | Sell |
-2,542,800
| Closed | -$81.6M | – | 1284 |
|
|
2017
Q1 | $81.6M | Sell |
2,542,800
-1,415,017
| -36% | -$45.4M | 0.19% | 131 |
|
|
2016
Q4 | $143M | Sell |
3,957,817
-832,450
| -17% | -$30.2M | 0.35% | 80 |
|
|
2016
Q3 | $220M | Buy |
4,790,267
+24,346
| +0.5% | +$1.12M | 0.53% | 47 |
|
|
2016
Q2 | $239M | Sell |
4,765,921
-1,126,881
| -19% | -$56.6M | 0.58% | 41 |
|
|
2016
Q1 | $315M | Sell |
5,892,802
-1,082,735
| -16% | -$57.9M | 0.75% | 25 |
|
|
2015
Q4 | $458M | Buy |
6,975,537
+238,750
| +4% | +$15.7M | 1.03% | 17 |
|
|
2015
Q3 | $380M | Sell |
6,736,787
-320,060
| -5% | -$18.1M | 0.85% | 21 |
|
|
2015
Q2 | $417M | Buy |
7,056,847
+1,915,309
| +37% | +$113M | 0.84% | 22 |
|
|
2015
Q1 | $320M | Buy |
5,141,538
+4,246,777
| +475% | +$265M | 0.64% | 29 |
|
|
2014
Q4 | $51.5M | Sell |
894,761
-33,910
| -4% | -$1.95M | 0.11% | 202 |
|
|
2014
Q3 | $49.9M | Sell |
928,671
-300,120
| -24% | -$16.1M | 0.11% | 187 |
|
|
2014
Q2 | $64.4M | Sell |
1,228,791
-1,173,667
| -49% | -$61.5M | 0.14% | 157 |
|
|
2014
Q1 | $127M | Sell |
2,402,458
-1,016,613
| -30% | -$53.7M | 0.29% | 87 |
|
|
2013
Q4 | $137M | Buy |
3,419,071
+872,762
| +34% | +$35M | 0.33% | 77 |
|
|
2013
Q3 | $96.2M | Buy |
2,546,309
+1,612,816
| +173% | +$60.9M | 0.26% | 105 |
|
|
2013
Q2 | $36.6M | Buy |
+933,493
| New | +$36.6M | 0.11% | 207 |
|